Although the APOE 4 gene significantly increases the likelihood of developing AD, many individuals who are APOE4 carriers do not develop the disease; it is hypothesized that APOE4 interacts with several factors, including obesity, that increase AD risk (Moser & Pike, 2017). Here, APOE is linked to obesity due to melanocortin 4 receptor deficiency.